Sucampo's glaucoma drug Rescula wins FDA clearance

12/13/2012 | American City Business Journals

The FDA approved the use of Sucampo Pharmaceuticals' Rescula, or unoprostone isopropyl, for intraocular pressure reduction in patients with ocular hypertension or open-angle glaucoma. Sucampo plans to launch the drug in the first quarter.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC